![](https://unicorn-nest.com/wp-content/uploads/2021/11/Junxin-Yingtai-Investment.jpg?x55332)
Related Funds
Fund Name | Location |
AL Trust | - |
Assertive Investment | - |
Avenue Growth Partners | District of Columbia, United States, Washington |
Baranco | - |
Charlottesville Angel Network | Charlottesville, United States, Virginia |
Cota Capital | California, San Francisco, United States |
Dahlman Rose & Company | New York, New York, United States |
IMG Worldwide | New York, New York, United States |
Impress Group | Japan, Tokyo |
Marigold Capital | Canada, Ontario, Toronto |
Millenna FVCI III | - |
NewHold Enterprises | New York, New York, United States |
NovEss | - |
Peak Ridge AgTech Fund | Boston, Massachusetts, United States |
Pioneer Fund | California, San Francisco, United States |
RockBridge Capital Partners | Columbus, Ohio, United States |
Seier Capital | Bern, Berne, Switzerland |
The Group Ventures | Canada, Ontario, Toronto |
Willfly Ventures | India, Maharashtra, Mumbai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Zhenge Biotech | $100M | 11 Jan 2022 | Shanghai, China | ||
Youdeyi | $1M | 01 Aug 2014 | Shenzhen, Guangdong, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Zhenge Biotech | $100M | 11 Jan 2022 | Shanghai, China | ||
Youdeyi | $1M | 01 Aug 2014 | Shenzhen, Guangdong, China |